Carlsbad, United States
Limmi, founded in 2022, operates within the interconnected realms of Analytics, Health Care, and Information Technology. With its headquarters in the United States, Limmi is carving a niche in the life sciences industry by simplifying data management and analysis for drug discovery and disease research.
The company's slogan, "Making life sciences data management & analysis simple," encapsulates its mission to leverage big data and machine learning for transforming patient outcomes. Limmi positions itself as a crucial player in facilitating insights through a modern data and analysis platform, thus appealing to sectors focused on healthcare advancements.
Recently, Limmi secured a $862.50K Seed Round investment, backed by Vinergy Capital on 18 October 2023. This injection of capital signals investor confidence in Limmi’s potential to drive innovation in life sciences, indicating a promising trajectory for growth and influence within its targeted industries.
